Evaluation of fourier transform infrared spectroscopy for the rapid identification of glycopeptide-intermediate Staphylococcus aureus

Journal of Antimicrobial Chemotherapy

Volumn 61, Issue 1, 2008, Pages 95-102

  Amiali, Nassim M ^a,b   Mulvey, Michael R ^c   Berger Bächi, Brigitte ^d   Sedman, Jacqueline ^b   Simor, Andrew E ^e   Ismail, Ashraf A ^b  

^a INSTITUTE FOR RESEARCH IN IMMUNOLOGY AND CANCER   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c PUBLIC HEALTH AGENCY OF CANADA   (Canada)

^d UNIVERSITY OF ZURICH   (Switzerland)

^e SUNNYBROOK RESEARCH INSTITUTE   (Canada)

Author keywords

Glycopeptide resistance; Heterogeneous GISA; Infrared spectroscopic method; MRSA

Indexed keywords

GLYCOPEPTIDE;

ACCURACY; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL GROWTH; BACTERIAL STRAIN; BACTERIUM IDENTIFICATION; CHEMOMETRICS; CONTROLLED STUDY; CULTURE MEDIUM; DATA ANALYSIS; GENE CLUSTER; GLYCOPEPTIDE INTERMEDIATE STAPHYLOCOCCUS AUREUS; INFRARED SPECTROSCOPY; INTERMETHOD COMPARISON; K NEAREST NEIGHBOR; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; NONHUMAN; PRINCIPAL COMPONENT ANALYSIS; STAPHYLOCOCCUS AUREUS; STRAIN IDENTIFICATION; VALIDATION PROCESS;

ALGORITHMS; ANTI-BACTERIAL AGENTS; DRUG RESISTANCE, BACTERIAL; GLYCOPEPTIDES; HUMANS; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; PRINCIPAL COMPONENT ANALYSIS; REPRODUCIBILITY OF RESULTS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS AUREUS;

EID: 37549020043     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkm400     Document Type: Article

References (43)

1. Hiramatsu K, Aritaka N, Hanaki H et al. Dissemination in Japanese hospitals of strains of Staphylococcus aureus heterogeneously resistant to vancomycin. Lancet 1997; 350: 1670-3.
2. Smith TL, Pearson ML, Wilcox KR et al. Emergence of vancomycin resistance in Staphylococcus aureus. N Engl J Med 1999; 340: 493-501.
3. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus - Pennsylvania, 2002. Morb Mortal Wkly Rep 2002; 51: 902.
4. Walsh TR, Howe RA. The prevalence and mechanisms of vancomycin resistance in Staphylococcus aureus. Ann Rev Microbiol 2002; 56 657-75.
5. Kralovic SM, Danko LH, Roselle GA. Laboratory reporting of Staphylococcus aureus with reduced susceptibility to vancomycin in United States department of veterans affairs facilities. Emerg Infect Dis 2002; 8: 402-7.
6. Sierdzski L, Leski T, Dick J et al. Evolution of a vancomycin-intermediate Staphylococcus aureus strain in-vivo multiple changes in the antibiotic resistance phenotypes of a single lineage of methicillin-resistant S. aureus under the impact of antibiotic administration. J Infect Dis 2003; 186: 661-7.
7. Moore MR, Perdreau-Remington F, Chambers HF. Vancomycin treatment failure associated with heterogeneous vancomycin- intermediate Staphylococcus aureus in a patient with endocarditis and in the rabbit model of endocarditis. Antimicrob Agents Chemother 2003; 47: 1262-6.
8. Tenover FC, Lancaster MV, Hill BC et al. Characterization of staphylococci with reduced susceptibilities to vancomycin and other glycopeptides. J Clin Microbiol 1998; 36: 1020-7.
9. Walsh TR, Bolmström A, Quarnstrom A et al. Evaluation of current methods of detecting vancomycin resistance and hetero-resistance in Staphylococcus aureus and other staphylococci. J Clin Microbiol 2001; 39: 2439-44.
10. Wootton M, Howe RA, Hillman R et al. A modified population analysis profile (PAP) method to detect hetero-resistance to vancomycin in Staphylococcus aureus in a UK hospital. J Antimicrob Chemother 2001; 47: 399-403.
11. Mallaval F-O, Carricajo A, Delavenna F et al. Detection of an outbreak of methicillin-resistant Staphylococcus aureus with reduced susceptibility to glycopeptides in a French hospital. Clin Microbiol Infect 2004; 10: 459-61.
12. Bhateja P, Purnapatrek K, Dube S et al. Characterisation of laboratory-generated vancomycin-intermediate resistant Staphylococcus aureus strains. Int J Antimicrob Agents 2006; 27: 201-11.
13. Hubert SK, Mohammed JM, Fridkin SK et al. Glycopeptide-intermediate Staphylococcus aureus: Evaluation of a novel screening method results of a survey of selected US hospitals. J Clin Microbiol 1999; 37: 3590-3.
14. Aucken HM, Warner M, Ganner M et al. Twenty months of screening for glycopeptide-intermediate Staphylococcus aureus. J Antimicrob Chemother 2000; 46: 639-40.
15. Wootton M, MacGowan AP, Walsh TR et al. A multi-center study evaluating the current strategies for isolating Staphylococcus aureus strains with reduced susceptibility to glycopeptides. J Clin Microbiol 2007; 45: 329-32.
16. Sieradzki K, Tomasz A. Gradual alterations in cell wall structure and metabolism in vancomycin-resistant mutants of Staphylococcus aureus. J Bacteriol 1999; 181: 7566-70.
17. Naumann D, Helm D, Labischinski H et al. The characterization of microorganisms by Fourier-transform infrared spectroscopy. In: Nelson WH, ed. Modern Techniques for Rapid Microbiological Analysis. New York: VCH Publishers, 1991; 43-96.
18. Kirschner C, Maquelin K, Pina P et al. Classification and identification of Enterococci: A comparative phenotypic, genotypic, and vibrational spectroscopic study. J Clin Microbiol 2001; 39: 1763-70.
19. Maquelin K, Kirschner C, Choo-Smith L-P et al. Prospective study of the performance of vibrational spectroscopies for rapid identification of bacterial and fungal pathogens recovered from blood cultures. J Clin Microbiol 2003; 41: 324-9.
20. Mariey L, Signolle JP, Amiel C et al. Discrimination, classification, identification of microorganisms using FTIR spectroscopy and chemometrics. Vibr Spectrosc 2001; 26: 151-9.
21. Miguel Gomez MA, Bratos Perez MA, Martin Gil FJ et al. identification of species of Brucella using Fourier transform infrared spectroscopy. J Microbiol Methods 2003; 55: 121-31.
22. Winder CL, Carr E, Goodacre R et al. The rapid identification of Acinetobacter species using Fourier transform infrared spectroscopy. J Appl Micobiol 2004; 96: 328-39.
23. Bouhedja W, Sockalingum GD, Pina P et al. ATR-FTIR spectroscopic investigation of E. coli transconjugants β-lactams-resistance phenotype. FEBS Lett 1997; 412: 39-42.
24. Kirschner C, Ngo Thi NA, Naumann D. FT-IR spectroscopic investigations of antibiotic sensitive and resistant microorganisms. In: Second Workshop on FT-IR Spectroscopy in Microbiology and Medical Diagnostic Robert Koch-Institute, Berlin, 2000.
25. Sockalingum GD, Bouhedja W, Pina P et al. ATR-FTIR spectroscopic investigation of imipenem susceptible and resistant Pseudomonas aeruginosa isogenic strains. Biochem Biophys Res Commun 1997; 232: 240-6.
26. Naumann D. Infrared spectroscopy in microbiology. In: Meyers RA, ed. Encyclopedia of Analytical Chemistry. Chichester: John Wiley & Sons Ltd, 2000; 102-31.
27. Golub GH, van Loan CF. The singular value decomposition and unitary matrices. In: Johns Hopkins University Press, ed. Matrix Computations Baltimore, MD: Johns Hopkins University Press, 1996; 70-71 and 73.
28. Jolliffe IT. Principal Component Analysis. Springer Series in Statistics. New York: Springer-Verlag, 1986.
29. Kohonen T. Self-Organizing Maps. Vol. 30 of Springer Series in Information Sciences. Berlin, Heidelberg, New York: Springer-Verlag, 1995.
30. Adams MJ. Pattern recognition II: Supervised learning. In: Barnett RA, ed. Chemometrics in Analytical Spectroscopy. Letchworth: The Royal Society of Chemists Analytical Spectroscopy Monographs. Turpin Distribution Services Ltd, 1995; 123-42.
31. Bourne R, Himmelreich U, Sharma A et al. Identification of Enterococcus, Streptocoocus, and Staphylococcus by multivariate analysis of proton magnetic resonance spectroscopic data from plate cultures. J Clin Microbiol 2001; 39: 2916-23.
32. Naumann D. Some ultrastructurall information on intact, living bacterial cells and related cell-wall fragments as given by FTIR. Infrared Phys 1984; 24: 233-8.
33. Magee J. Whole-organism fingerprinting. In: Goodfelow M, O'Donnel AG, eds. Handbook of New Bacterial Systematics. New York: Harcourt Brace, 1993; 383-427.
34. Kümmerle M, Scherer S, Seiler H. Rapid and reliable identification of food-borne yeasts by Fourier-transform infrared spectroscopy. Appl Environ Microbiol 1998; 64: 2207-14.
35. Diem M. Introduction to Modern Vibrational Spectroscopy. New York: John Wiley and Sons, 1994.
36. Alban JO, Fiamingo FG. Fourier transform infrared spectroscopy. In: Rousseau DL, ed. Optical Techniques in Biological Research. New York: Academic Press, 1984; 133-79.
37. Mordechai S, Salman A, Argov S et al. In: Mahadevan-Jansen A, Puppels GJ, eds. Biomedical Spectroscopy: Vibrational Spectroscopy Other Novel Techniques, Proceedings of SPIE. 2000; 3918: 66-77.
38. Centers for Disease Control and Prevention. Vancomycin-resistant Staphylococcus aureus - New York, 2004. Morb Mortal Wkly Rep 2004; 53: 322-3.
39. Clinical and Laboratory Standards Institute. Performance Standards for Antimicrobial Susceptibility Testing: Sixteenth Informational Supplement M100-S16. CLSI, Wayne, PA, USA, 2006.
40. Boyle-Vavra S, Berke SK, Lee JC et al. Reversion of the glyco-peptide resistance phenotype in Staphylococcus aureus clinical isolates. Antimicrob Agents Chemother 2000; 44: 272-7.
41. Vaudaux P, Francois P, Berger-Bachi B et al. in vivo emergence of subpopulations expressing teicoplanin or vancomycin resistance phenotypes in a glycopeptide-susceptible, methicillin-resistant strain of Staphylococcus aureus. J Antimicrob Chemother 2001; 47: 163-70.
42. Hiramatsu K. Vancomycin-resistant Staphylococcus aureus: A new model of antibiotic resistance. Lancet Infect Dis 2001; 1: 147-55.
43. Plipat N, Livni G, Bertram H et al. Unstable vancomycin hetero-resistance is common among clinical isolates of methicillin-resistant Staphylococcus aureus. J Clin Microbiol 2005; 43: 2494-6.